Gelatin-based microneedle patch for minimally-invasive extraction of bodily fluids

Patent metadata

Field	Value
Publication number	US-12544547-B2
Application number	US-202117791452-A
Country	US
Kind code	B2
Filing date	Jan 7, 2021
Priority date	Jan 10, 2020
Publication date	Feb 10, 2026
Grant date	Feb 10, 2026

Abstract

A gelatin-based (e.g., gelatin methacryloyl (GelMA)) patch is disclosed with an array of microneedles (MNs) for minimally invasive sampling of bodily fluids such as interstitial fluid (ISF). The properties of the patch can be tuned by altering the concentration of the GelMA prepolymer and the crosslinking time. The GelMA-based MN patch demonstrated efficient extraction of ISF. Furthermore, in experimental testing, the patch efficiently and quantitatively detects glucose and vancomycin in ISF in an in vivo study. This minimally invasive approach of extracting ISF with a GelMA microneedle enables to detection and analysis of target molecules from patients. The target molecules captured in the patch may be released and analyzed to detect the presence of and/or concentration of target molecules. In other embodiments, the patch itself may be analyzed directly to detect the presence of and/or concentration of target molecules.

First claim

What is claimed is:

1 . A method for extracting fluid from living tissue using a patch comprising:
providing a patch comprising a base or substrate having a plurality of microneedles extending away from the surface of the base, wherein the base and the plurality of microneedles are formed from crosslinked gelatin-based material and wherein the patch has a swelling ratio between about 100% to about 500% (wt. basis); applying the patch to the living tissue so that the plurality of microneedles penetrate into the living tissue; absorbing one or more drugs, analytes, compounds, molecules, or biomarkers contained in the fluid of the living tissue into the plurality of microneedles; and removing the patch from the living tissue.

2 . The method of claim 1 , wherein the gelatin-based material comprises methacryloyl (GelMA).

3 . The method of claim 1 , further comprising:
extracting the one or more drugs, analytes, compounds, molecules, or biomarkers from the plurality of microneedles.

4 . The method of claim 3 , further comprising detecting the presence of the one or more drugs, analytes, compounds, molecules, or biomarkers extracted from the plurality of microneedles.

5 . The method of claim 3 , further comprising measuring the concentration of the one or more drugs, analytes, compounds, molecules, or biomarkers extracted from the plurality of microneedles.

6 . The method of claim 1 , further comprising analyzing the removed patch directly to determine the presence and/or concentration of the one or more drugs, analytes, compounds, molecules, or biomarkers.

7 . The method of claim 6 , wherein analyzing comprises detecting a color and/or color change of the patch.

8 . The method of claim 6 , wherein analyzing comprises detecting fluorescence light emitted from the patch.

9 . The method of claim 1 , wherein the plurality of microneedles absorb interstitial fluid or blood.

10 . The method of claim 1 , wherein the patch has a swelling ratio between about 200% to about 500% (wt. basis).

11 . The method of claim 1 , wherein the patch has a compressive modulus within the range of about 2 to about 10 MPa.

12 . The method of claim 1 , wherein the patch has a compressive modulus within the range of about 3 MPa to about 8 MPa.

13 . The method of claim 1 , wherein the one or more drugs, analytes, compounds, molecules, or biomarkers comprises an endogenous molecule or compound.

14 . The method of claim 1 , wherein the one or more drugs, analytes, compounds, molecules, or biomarkers comprises an exogenous molecule or compound.

15 . The method of claim 1 , wherein the plurality of microneedles have varying lengths.

16 . The method of claim 1 , wherein the plurality of microneedles have a chromogenic or fluorogenic compound contained therein that is responsive to one or more drugs, analytes, compounds, molecules, or biomarkers extracted from the plurality of microneedles.

17 . The method of claim 1 , wherein the patch is removed less than one hour after applying the patch to the living tissue.

18 . A patch for extracting fluid from living tissue comprising:
a base or substrate having a plurality of microneedles extending away from the surface of the base, wherein the base and the plurality of microneedles are formed from crosslinked gelatin-based material, and wherein the plurality of microneedles contain one or more chromogenic or fluorogenic compounds therein that change color and/or fluorescence in response to the presence of one or more drugs, analytes, compounds, molecules, or biomarkers, wherein the patch has a swelling ratio between about 100% to about 500% (wt. basis).

19 . The patch of claim 18 , further comprising an imaging device configured to obtain an image of the patch.

20 . A method for extracting fluid from living tissue using a patch comprising:
providing a patch comprising a base or substrate having a plurality of microneedles extending away from the surface of the base, wherein the base and the plurality of microneedles are formed from crosslinked gelatin-based material and wherein the patch has a compressive modulus within the range of about 2 to about 10 MPa; applying the patch to the living tissue so that the plurality of microneedles penetrate into the living tissue; absorbing one or more drugs, analytes, compounds, molecules, or biomarkers contained in the fluid of the living tissue into the plurality of microneedles; and removing the patch from the living tissue.

Assignees

• Univ California

Inventors

• Khademhosseini Alireza
• Sun wujin

Classifications

• A61M2037/0061

  Methods for using microneedles · CPC title

• A61M37/0015 Primary

  by using microneedles · CPC title

• A61M2037/0046

  Solid microneedles · CPC title

• A61M2037/0023

  Drug applicators using microneedles · CPC title

• A61B5/150984

  Microneedles or microblades · CPC title